BNET Industries

Market Cap:$113.2B
Last Fiscal Year Sales:$24.1B
  • Public
  • US
Dow Jones Description

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.

Chairman, President & Chief Executive Officer
Richard T. Clark
Number of Employees 55,200
Contact Information

1 Merck Dr

PO Box 100

Whitehouse Station, New Jersey 08889

www.merck.com

(908) 423-1000

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • SEC Hunts for Insider Trading

    12/09/09 - Merger / Acquisition - View Story

  • Pfizer, Merck, 3M Lift Dow

    12/09/09 - Bond / Stock Rating - View Story

  • The Next AIDS Crisis

    12/09/09 - Product Announcement - View Story

  • Stocks Post Moderate Gains Following Choppy Trading Session - U.S. Commentary

    12/09/09 - Bond / Stock Rating - View Story

  • Genzyme names new board member

    12/11/09 - Merger / Acquisition - View Story

  • Reportlinker Adds Growth Factors Blood And Tissue - A World Report

    12/03/09 - Joint Venture / Alliance - View Story

  • RPT-Swiss stocks - Factors to watch on Dec 2

    12/02/09 - Joint Venture / Alliance - View Story

  • Addex Pharmaceuticals (ADXN.SW) Extends Merck & Co., Inc. MRK Research Linkup

    12/02/09 - New Investment - View Story

  • Research and Markets: Osteoporosis Therapeutics - a Global Market Perspective: the Most Comprehensive Report in...

    11/26/09 - Product Announcement - View Story

  • Idera Pharmaceuticals and Merck extend research collaboration

    11/27/09 - Joint Venture / Alliance - View Story

  • UPDATE:Merck Cholesterol Drug Prescriptions Dropped Last Week

    11/24/09 - Financial Announcement - View Story

  • Merck MRK Declares $0.38 Quarterly Dividend; 4.1% Yield; Announces $3B Common Buyback

    11/24/09 - Stock Split / Dividend - View Story

  • Early and Often: A Drug Investor's Dream

    12/08/09 - Bond / Stock Rating - View Story

  • Texas District Court Dismisses Vioxx Lawsuit Against Merck

    11/23/09 - Lawsuit Filed - View Story

  • Stocks in focus for Wednesday

    12/01/09 - Merger / Acquisition - View Story

  • Nonprofit Dispensary of Hope pharmacy serves needs of uninsured

    11/19/09 - Joint Venture / Alliance - View Story

  • Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.

    11/22/09 - Merger / Acquisition - View Story

  • Merck's new CP wins S&P's top-notch short-term rating

    11/18/09 - Product Announcement - View Story

  • Schering-Plough, Merck Settle $41.5 Million Class Action Lawsuit

    11/17/09 - Legal Settlement - View Story

News & Analysis

merck & co. inc. and novartis ag - All News and Analysis

Decision Makers

Name (plus bio) Position
Adam Schechter President, Human Health, US
Margaret G. McGlynn President, Vaccine Division
Peter S. Kim President, Res Laboratories
Willie A. Deese President, Manufacturing Division
Adel A.F. Mahmoud Chief Medical Advisor, Vaccines & Infectious Diseases
Irene Qualters Division CIO, Research Info Services
J. Chris Scalet Senior Vice President, Global Services & Chief Information Officer
Douglas A. Greene Executive Vice President, Clinical Sciences & Prod Development
Kenneth C. Frazier Executive Vice President and President, Global Human Health
Bruce N. Kuhlik Senior Vice President & General Counsel
Marcia J. Avedon Senior Vice President, HR
Mirian Graddick-Weir Senior Vice President, Human Resources
Caroline Dorsa Vice President & Treasurer
Celia A. Colbert Vice President, Secretary & Assistant General Counsel
Joan Wainwright Vice President, Public Affairs
John Canan Vice President & Controller
Randall T. Freides Vice President, Corp Audit Services
Richard C. Henriques Vice President, Finance, Global Human Health Division
Dan Guaglianone Executive Director, Recruiting & Staffing
Jim Schaeffer Executive Director, Licensing and External Research
Raymond Hill Executive Director, External Research
Jeff Saltzman Senior Director, Computing
Michele Esposito Director of Executive Recruiting
Amos Smith Consultant
Astra Merck
Elias Abrutyn
Eugene P Frenkel
J M Edwards Johnson
JAMES C BALLENGER
John H Hord
JOS E J LLINAS
Lawrence G Raisz
M Boyd Gillespie
Marjorie A Bowman
Mark H Beers
Michael W Rich
Paul R Katz
Terry T Fulmer
Thomas V Jones
Victor W Henderson

Board of Directors

Name (plus bio) Position
Richard T. Clark Chairman, President & Chief Executive Officer
Anne M. Tatlock Board of Directors
Carlos E Represas Board of Directors
Johnnetta B. Cole Board of Directors
Leslie A. Brun Board of Directors
Peter C. Wendell Board of Directors
Rochelle B. Lazarus Board of Directors
Samuel O. Thier MD Board of Directors
Steven F. Goldstone Board of Directors
Thomas E Shenk Board of Directors
Thomas H. Glocer Board of Directors
Wendell P. Weeks Board of Directors
William B. Harrison Jr. Board of Directors
William G. Bowen Board of Directors
William N. Kelley Board of Directors

Merck & Co., Inc. * Chairman, President and Chief Executive Officer, Merck & Co., Inc., 2007 * CEO and President, Merck & Co., Inc., 2005-2007 * President, Merck Manufacturing Division, 2003-2005 * Chairman and CEO, Medco Health Solutions, Inc., 2002-2003 * President, Medco Health Solutions, Inc. (Merck-Medco Managed Care), 2000-2002 * Executive Vice President/Chief Operating Officer, Merck-Medco Managed Care, L.L.C., 1997-2000 * Senior Vice President, Quality Commercial Affairs, MMD, 4/1997-5/1997 * Senior Vice President, North American Operations, MMD, 5/1996-3/1997 * Vice President, North American Operations, MMD, 10/1994-5/1996 * Vice President, Procurement & Materials Management, MMD, 1993-1994 * Vice President, Materials Management & Management Engineering, MMD, 1991-1993 * Executive Director, Management Engineering, Merck Pharmaceutical Manufacturing Division, 1989-1991 * Senior Director, Management Engineering, Merck Sharp & Dohme/MPMD, 1986-1989 * Director, Operations Improvement, MPMD, 1985-1986 * Senior Manager, Industrial Engineering, MPMD, 1984-1985 * Manager, Industrial Engineering, MSD, West Point, 1983-1984 * Production Manager, MSD, Elkton Pharmaceutical Laboratories, 1981-1983 * Senior New Products Planner, 1978-1981 * Quality Control Inspector, Industrial Engineer, Quality Control Analyst, Lead Supervisor-Pharmaceutical Production, MSD, 1972-1978 Education * M.B.A., American University, 1970 * B.A., Liberal Arts, Washington & Jefferson College, 1968 Affiliations * Past Chairman of Pharmaceutical Research and Manufacturers of America (PhRMA), 2008 Military * Lieutenant, U. S. Army, 1970-1972

Organization Position Status
Merck & Co. Inc. Chairman, President & Chief Executive Officer Current
Merck & Co. Research & Development President Current
Pharmaceutical Research and Manufacturers of America Chairman Current
Medco Health Solutions, Inc. CEO Former
Medco Health Solutions, Inc. chairman Former
Merck & Co. Inc. Board of Directors Former
American University M.B.A Former
Washington & Jefferson College B.A., Liberal Arts Former

Organization Position Status
Merck & Co. Inc. President, Human Health, US Current

Organization Position Status
Merck & Co. Inc. President, Vaccine Division Current

Peter S. Kim Executive Vice President and President, Merck Research Laboratories Professional Experience Merck & Co., Inc. * Executive Vice President and President, Merck Research Laboratories, 2008 to present * President, Merck Research Laboratories, 2003-2008 * Executive Vice President, Research and Development, MRL, 2001 - 2002 Other Professional Experience * Associate Head, Department of Biology, M.I.T., 1999 - 2001 * Investigator, Howard Hughes Medical Institute, 1997 - 2001 * Professor of Biology, M.I.T., 1995 - 2001 * Member, Whitehead Institute for Biomedical Research, 1992 - 2001 * Associate Professor of Biology, M.I.T., 1992 - 1995 * Assistant Investigator, Howard Hughes Medical Institute, 1990 - 1993 * Assistant Professor of Biology, M.I.T., 1988 - 1992 * Whitehead Fellow, Whitehead Institute for Biomedical Research, 1985 - 1988 Education * Ph.D., Biochemistry, Stanford University, 1985 * A.B., Chemistry, Cornell University, 1979 Board Memberships and Other Affiliations * Member, Board of Trustees, Alfred P. Sloan Foundation, 2009 to present * Member, Council, Institute of Medicine, National Academy of Sciences, 2006 to present * Member, Board of Directors, Whitehead Institute for Biomedical Research, 2005 to present Elected Memberships * Fellow, American Academy of Arts & Sciences, 2008 * Member, Institute of Medicine, National Academy of Sciences, 2000 * Fellow, American Association for the Advancement of Science, 1999 * Fellow, Biophysical Society, 1999 * Member, Korean Academy of Science and Technology, 1999 * Fellow, American Academy of Microbiology, 1997 * Member, National Academy of Sciences, 1997 Selected Awards * Harvey Lecture, The Harvey Society, 2002 * Hans Neurath Award, Protein Society, 1999 * Ho-Am Prize for Basic Science, Samsung Foundation, 1998 * Pfizer Animal Health Award, 1995 * Dupont Merck Young Investigator Award, 1994 * Eli Lilly Award in Biological Chemistry, 1994 * National Academy of Sciences Award in Molecular Biology, 1993

Organization Position Status
Merck & Co. Inc. President, Res Laboratories Current
Close Concerns, Inc. Current

Professional Experience Merck & Co., Inc. * Executive Vice President and President, Merck Manufacturing Division, 2008 * President, Merck Manufacturing Division, 2005-2007 * Senior Vice President, Global Procurement, 2004-2005 Other Professional Experience GlaxoSmithKline * Senior Vice President, Global Procurement and Logistics, GlaxoSmithKline, 2001-2004 * Senior Vice President and Director, Purchasing, Worldwide Supply Operations, SmithKline Beecham Pharmaceuticals, 1997-2000 * Vice President and Director, Purchasing, SmithKline Beecham Pharmaceuticals, 1995-1996 * Director, Purchasing, SmithKline Beecham Clinical Laboratory Sector, 1992-1995 Kaiser Permanente * Vice President, Purchasing, Kaiser Permanente, 1996-1997 Digital Equipment Corporation * Site Manager, Digital Equipment Corporation, 1991-1992 * Disk Operations Manager, Digital Equipment Corporation, 1989-1990 * Site Materials Manager, Digital Equipment Corporation, 1987-1989 * Site Purchasing Manager, Digital Equipment Corporation, 1985-1987 * Business Materials Manager, Digital Equipment Corporation, 1983-1985 * Purchasing Manager, Digital Equipment Corporation, 1981-1983 * Senior Buyer, Digital Equipment Corporation, 1980-1981 * Buyer, Digital Equipment Corporation, 1977-1979 Education * M.B.A., Western New England College, 1983 * B.A., Business Administration, North Carolina A&T State University, 1977

Organization Position Status
Merck & Co. Inc. President, Manufacturing Division Current

Organization Position Status
Merck & Co. Inc. Chief Medical Advisor, Vaccines & Infectious Diseases Current

Organization Position Status
Merck & Co. Inc. Division CIO, Research Info Services Current
Ageia, Inc. Vice President Software Engineering Current
Silicon Graphics, Inc. senior vice president Former
Merck & Co. Inc. vice president Former
University of Detroit Mercy School of Law MA in Computer Science Former

J. Chris Scalet Executive Vice President, Global Services, and Chief Information Officer Professional Experience Merck & Co., Inc. * Executive Vice President, Global Services, and Chief Information Officer, 2008 * Senior Vice President, Global Services, and Chief Information Officer, 2006-2007 * Senior Vice President, Information Services, and Chief Information Officer, 2003-2005 Other Professional Experience * International Paper; Senior Vice President, Information Technology and CIO, 1998-2003 * MAPCO Inc.; Vice President, Information Technology and CIO, 1993-1997 Education * B.S., Management Science and Computer Systems, Oklahoma State University * Executive Development Program, Kellogg School of Management, Northwestern University Affiliations Board Memberships * Past Honorary Conference Chair BDPA (Black Data Processing Associates) * Research Board, 2003 to present

Organization Position Status
Merck & Co. Inc. Senior Vice President, Global Services & Chief Information Officer Current
Netezza Corporation Board of Directors Current
International Paper Company Senior Vice President, Information Technology & Chief Information Officer Former

Organization Position Status
Merck & Co. Inc. Executive Vice President, Clinical Sciences & Prod Development Current

Organization Position Status
Merck & Co. Inc. Executive Vice President and President, Global Human Health Current
Merck & Co. Inc. General Counsel & Senior Vice President Former

Bruce N. Kuhlik Executive Vice President and General Counsel Professional Experience Merck & Co., Inc. * Executive Vice President and General Counsel, 2008 * Senior Vice President and General Counsel, 2007 * Vice President and Associate General Counsel, 2005-2007 Other Professional Experience Pharmaceutical Research and Manufacturers of America * Senior Vice President and General Counsel, 2002-2005 Covington & Burling * Partner, 1990-2002 * Associate, 1982-1984, 1986-1990 U.S. Department of Justice * Assistant to the Solicitor General, 1984-1986 Honorable Levin H. Campbell, U.S. Court of Appeals for the First Circuit * Law Clerk, 1981-1982 Education * J.D., Harvard Law School, 1981 * A.B., Economics, Harvard College, 1978 Bar Admissions * Pennsylvania (Limited In-House Counsel License), 2005 * Supreme Court of the United States, 1985 * District of Columbia, 1982

Organization Position Status
Merck & Co. Inc. Senior Vice President & General Counsel Current
Merck & Co. Inc. Vice President & Associate General Counsel Former

Organization Position Status
Merck & Co. Inc. Senior Vice President, HR Current
Lincoln Financial Group Current
Honeywell International Inc. Vice President, Corporate Human Resources Former

Mirian Graddick-Weir, Ph.D. Executive Vice President, Human Resources PROFESSIONAL EXPERIENCE Merck & Co., Inc. * Executive Vice President, Human Resources, 2008 * Senior Vice President, Human Resources, 2006-2007 OTHER PROFESSIONAL EXPERIENCE AT&T * Executive Vice President, Human Resources and Employee Communications, 2004-2006 * Executive Vice President, Human Resources, 1999-2004 * Chief Human Resources Officer, Consumer Services Company, 1998-1999 * Vice President, Human Resources, Business Effectiveness, 1996-1998 * Vice President, Human Resources, 1995-1996 * Vice President, Multimedia Products and Executive HR, 1994-1995 * Director, Customer Service, Consumer Communications Services, 1991-1993 * Director, Human Resources, International Communications Services, 1989-1991 * Special Assistant to the Vice Chairman, 1988-1989 * Corporate Human Resources, 1981-1988 EDUCATION * Ph.D., Industrial/Organizational Psychology, Penn State, 1981 * M.S., Industrial/Organizational Psychology, Penn State, 1978 * B.A., Psychology, Hampton University, 1976 AFFILIATIONS Board Memberships: * Cornell Center for Advanced Human Resource Studies * The Harleysville Group Insurance Company * Jersey Battered Women's Services, Inc. * National Academy of Human Resources * Human Resources Policy Association * National Medical Fellowships * Personnel Roundtable * Kent Place School AWARDS * Distinguished Psychologist in Management, 2003 * HR Executive of the Year, 2001 * AT&T Catherine B. Cleary – Woman of the Year, 1990

Organization Position Status
Merck & Co. Inc. Senior Vice President, Human Resources Current
AT&T Inc. Division Executive Vice President, HR Former

Organization Position Status
Merck & Co. Inc. Vice President & Treasurer Current
Merck Holdings Inc. Treasurer Current
Public Service Enterprise Group Incorporated Board of Directors Current

Organization Position Status
Merck & Co. Inc. Vice President, Secretary & Assistant General Counsel Current
Frosst Laboratories Inc. Secretary & Vice President Current

Organization Position Status
Merck & Co. Inc. Vice President, Public Affairs Current

Organization Position Status
Merck & Co. Inc. Vice President & Controller Current

Organization Position Status
Merck & Co. Inc. Vice President, Corp Audit Services Current

Organization Position Status
Merck & Co. Inc. Vice President, Finance, Global Human Health Division Current

Organization Position Status
Merck & Co. Inc. Executive Director, Recruiting & Staffing Current

Organization Position Status
Merck & Co. Inc. Executive Director, Licensing and External Research Current
UCSD-CONNECT Director Current

Organization Position Status
Merck & Co. Inc. Executive Director, External Research Current

Organization Position Status
Merck & Co. Inc. Senior Director, Computing Current
Merck & Co. Inc. Senior Director, Computing Former

Organization Position Status
Merck & Co. Inc. Director of Executive Recruiting Current

Organization Position Status
Columbia University Visiting Professor Current
Cambridge University Visiting Professor Current
Red Abbey, LLC Senior Advisor Current
Genentech, Inc. Consultant Current
Auckland University Visiting Professor Current
Incyte Corporation Consultant Current
University of Pennsylvania Professor Current
Merck & Co. Inc. Consultant Current
University of Pennsylvania Chairman Current
Kosan Biosciences, Inc. Board Advisor Current
Dihedron Corp Board Advisor Current
Pharmacopeia Drug Discovery Inc. Board Advisor Current
Provid Pharmaceuticals, Inc. Board of Directors Current
Monell Chemical Senses Center Member Current
The Rockefeller University Research Associate Former
The Rockefeller University Ph.D. Former
Bucknell University M.S. Degrees Former
Bucknell University B.S. Former
The Rockefeller University B.S. Former

Organization Position Status
Merck & Co. Inc. Current

Organization Position Status
Merck & Co. Inc. Current
Drexel University College of Medicine Associate Dean for Faculty Affairs Former

Organization Position Status
Merck & Co. Inc. Current
Boston Medical Center Chief Former
Harvard Medical School Assistant Clinical Professor Former
SUNY Downstate Medical Center Former

Organization Position Status
Merck & Co. Inc. Current

Organization Position Status
Merck & Co. Inc. Current

Organization Position Status
Merck & Co. Inc. Current
Case Western Reserve University Physician-in-Chief Former
Case Western Reserve University Chief Former

Organization Position Status
Merck & Co. Inc. Current
Georgetown University Associate Professor of Physiology and Biophysics Former

Organization Position Status
Merck & Co. Inc. Current

Organization Position Status
Merck & Co. Inc. Current
University of Medicine & Dentistry of New Jersey Clinical Associate Professor of Medicine Former
University of Medicine and Dentistry of New Jersey Clinical Associate Professor of Medicine Former
University of Pittsburgh School of Medicine FACS Associate Professor Former

Organization Position Status
Merck & Co. Inc. Current
Montefiore Medical Center Director Former
Sinai Hospital of Baltimore Director Former
New York University Director, Division of Geriatrics and The Diane Former

Organization Position Status
Merck & Co. Inc. Current
Drexel University Clinical Professor of Medicine Former

Organization Position Status
Merck & Co. Inc. Current
Hackensack University Medical Center Clinical Assistant Professor Former
Maine Medical Center Geriatrician Former
University of Washington Cardiology Fellow Former
Washington University School of Medicine Associate Professor of Medicine Former

Organization Position Status
Merck & Co. Inc. Current
University of Texas Health Science Center Director, Center on Aging Former
Drexel University College of Medicine Assistant Professor Former
Yale University School of Medicine Clinical Professor Former
Weill Medical College of Cornell University Professor of Medicine Former

Organization Position Status
Merck & Co. Inc. Current

Organization Position Status
Merck & Co. Inc. Current
Temple University School of Medicine Clinical Associate Professor of Medicine Former
Thomas Jefferson University Clinical Assistant Professor of Emergency Medicine Former
University of Pennsylvania School of Medicine Adjunct Assistant Professor of Medicine Former

Organization Position Status
Merck & Co. Inc. Current

Organization Position Status
Close Concerns, Inc. Current
Merck & Co. Inc. Board of Directors Current
Franklin Resources, Inc. Board of Directors Current
Fortune Brands, Inc. Director Current
Fiduciary Trust Company International Chief Executive Officer Former
Ballet Theatre Foundation, Inc. president Former
Smith Barney vice president Former
Fiduciary Trust Company International Director, Fortune Brands Former
Fiduciary Trust Company International investment manager Former
Ballet Theatre Foundation, Inc. trustee Former
Fiduciary Trust Company International Chairman Former
Merck & Co. Inc. Director Former
New York University Master's degree in economics Former
Fiduciary Trust Company member Former
Council on Foreign Relations member Former

Organization Position Status
Nestle S.A. President, Mexico Current
Cseries Chairman of the Board Current
Regional Jets Chairman of the Board Current
Latin American Chamber of Commerce Chairman Current
Bombardier Capital Funding Limited Chairman of The Board Current
Vitro Board of Directors Current
Merck & Co. Inc. Board of Directors Current
Latin American Chamber of Commerce President Former

Organization Position Status
Merck & Co. Inc. Board of Directors Current
Spelman College president Former

Organization Position Status
Automatic Data Processing, Inc. Board of Directors Current
Merck & Co. Inc. Board of Directors Current

Managing Director, Sierra Ventures ( technology-oriented venture capital firm). Chairman, Princeton University Investment Company. Merck Director since 2003.

Organization Position Status
Merck & Co. Inc. Board of Directors Current

Organization Position Status
Ogilvy & Mather Worldwide, Inc. Chairman & Chief Executive Officer Current
Columbia Business School Board of Overseers Current
World Wildlife Fund, Inc. Board of Directors Current
American Museum of Natural History Board of Directors Current
New York Presbyterian Hospital Board of Directors Current
Merck & Co. Inc. Board of Directors Current
General Electric Company Board of Directors Current
Ogilvy & Mather Worldwide, Inc. Board of Directors Current
The Business Council Member Current
Council on Foreign Relations Member Current
Advertising Women of New York, Inc. Member Current
Ogilvy & Mather Worldwide, Inc. President & Chief Operating Officer Former
Ogilvy & Mather Worldwide, Inc. President, Ogilvy North America Former
Ogilvy & Mather Worldwide, Inc. President, Advertising Former
Ogilvy & Mather Worldwide, Inc. General Manager, US Former
Unilever N.V. Account Management Former
Kraft Foods Inc. Account Management Former
American Express Company Account Management Former
Smith College Chairman, Board of Trustees Former
Columbia University MBA Former
Smith College Bachelor's Degree, Psychology Former

Organization Position Status
Harvard Medical School Professor of Medicine Current
Institute for Health Metrics Professor of Medicine and Professor of Health Care Policy at Harvard Medical School Current
Close Concerns, Inc. Current
American Philosophical Society Board of Directors Current
Charles River Laboratories, Inc. Board of Directors Current
Merck & Co. Inc. Board of Directors Current
Partners HealthCare System, Inc. Chief Executive Officer Former
Massachusetts Gen Hospital President Former
Massachusetts General Hospital President Former
National Academy of Sciences President Former
Brandeis University President Former
Partners HealthCare System, Inc. President Former
Federal Reserve Bank of Boston Director, Charles River Laboratories Former
Yale University School of Medicine Chairman of the Department of Internal Medicine Former
The Commonwealth Fund Chairman Former
Federal Reserve Bank of Boston Chairman Former
Merck & Co. Inc. Director Former
Federal Reserve Bank of Boston Board of Directors Former

Steven F. Goldstone has served on our Board of Directors since July of 2004. He currently manages Silver Spring Group, a private investment firm. From 1995 until his retirement in 2000, Mr. Goldstone was chairman and chief executive officer of RJR Nabisco, Inc. (which was subsequently named Nabisco Group Holdings following the reorganization of RJR Nabisco, Inc.). Prior to joining RJR Nabisco, Inc., Mr. Goldstone was a partner at Davis Polk & Wardwell, a law firm in New York City. He is also a director of American Standards Companies, ConAgra Foods, Inc., Retail DNA, Inc. and New Castle Hotels, chairman of Ridgefield Senior Center Foundation, chairman of the Roundabout Theatre Company (New York City) and a member of the College Board of Overseers at the University of Pennsylvania.

Organization Position Status
Greenhill & Co, Inc. Chairman, Compensation Committee, Member, Nominating and Governance Committee Current
Roundabout Theatre Company Chairman Current
Greenhill Capital Partners, LLC Chairman, Compensation Committee, Member, Nominating and Governance Committee Current
ConAgra Foods, Inc. Non-Executive Chairman Current
American Standard Companies, Inc. Board of Directors Current
New Castle Hotels, LLC Director Current
Merck & Co. Inc. Board of Directors Current
ConAgra Foods, Inc. Director Current
Kraft Foods Inc. chief executive officer Former
Davis Polk & Wardwell partner Former
Kraft Foods Inc. chairman Former
Greenhill & Co, Inc. Board of Directors Former
University of Pennsylvania member Former

Organization Position Status
Lifeheart.Com Director of Cv Therapeutics Current
Signum Biosciences, Inc. Chairman Current
Merck & Co. Inc. Board of Directors Current
Ranexa Director Current
American Academy of Microbiology Board of Directors Current
CV Therapeutics Inc. Board of Directors Current
Cell Genesys, Inc. Board of Directors Current
National Academy of Sciences Board of Directors Current
American Academy of Microbiology Member Current
National Academy of Sciences Member Current
American Academy of Microbiology President Former
Merck & Co. Inc. member Former
Rutgers University Ph.D. In Microbiology Former
University of Detroit Mercy School of Law B.S. In Biology Former

Tom Glocer is Chief Executive Officer of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals. It combines unmatched industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. Mr. Glocer joined Reuters Group in 1993 as Vice President and Deputy Counsel, Reuters America. He held a number of senior leadership positions at Reuters, including President of Reuters LatAm and Reuters America, before being named CEO of Reuters Group PLC in July 2001. He is a director of Merck & Co., Inc., the Columbia College Board of Visitors, the President's Council on International Activities at Yale University, the Advisory Board of the Judge Institute of Management at Cambridge University, the International Business Council of the World Economic Forum, the European Business Leaders Council, the Board of Directors of the Partnership for New York City, the International Advisory Board of British American Business Inc., the International Business Advisory Council London, the Corporate Advisory Board of Tate Britain and the Madison Council of the Library of Congress. Mr. Glocer holds a bachelor's degree in political philosophy from Columbia University and a J.D. from Yale Law School.

Organization Position Status
Thomson Reuters plc Chief Executive Officer Current
Thomson Reuters Corporation Chief Executive Officer Current
Merck & Co. Inc. Board of Directors Current
Thomson Reuters plc Board of Directors Current
Thomson Reuters Corporation Board of Directors Current
Reuters Group plc Chief Executive Officer Former
Davis Polk & Wardwell Merger and Acquisition Lawyer Former
Reuters Group plc Board of Directors Former

Organization Position Status
Corning Incorporated Spacer, Chairman and Chief Executive Officer Current
Merck & Co. Inc. Board of Directors Current
Corning Incorporated Chief Operating Officer Former
Corning Incorporated Executive Vice President Former
Corning Incorporated Senior Vice President Former
Optoelectronics, Inc Senior Vice President Former
Optoelectronics, Inc Deputy General Manager Former
Asahi Glass Co., Ltd. general manager Former
Corning Incorporated Deputy General Manager Former
Merck & Co. Inc. Director Former
Corning Incorporated Board of Directors Former

Organization Position Status
Cousins Properties Incorporated Chairman, Jpmorgan Chase & Co. Current
Merck & Co. Inc. Board of Directors Current
Merck & Co. Inc. Director Current
J.P. Morgan & Co. Chief Executive Officer Former
J.P. Morgan & Co. President Former
J.P. Morgan & Co. Vice Chairman Former

Organization Position Status
Close Concerns, Inc. Current
Merck & Co. Inc. Board of Directors Current
American Express Company Board of Directors Former

Organization Position Status
University of Pennsylvania School of Medicine Professor of Medicine Current
Advanced Bio-Surfaces, Inc Board of Directors Current
Beckman Coulter, Inc. Board of Directors Current
Dolmatconnell & Partners, Inc Board of Directors Current
Emory University Board of Directors Current
American Philosophical Society Board of Directors Current
GenVec, Inc. Director Current
Merck & Co. Inc. Board of Directors Current
Emory University Trustee Current
American Philosophical Society Member Current
The University of Pennsylvania Health System Chief Executive Officer Former
Duke University Medical Center Chief of the Division Former
University of Pennsylvania Executive Vice President Former
Duke University Medical Center Professor of Medicine Former
Merck & Co. Inc. Director Former

Executive News

  • Kodak Reinvents the Trade Show Experience at Print 09

    Business Wire - 8/26/09 - View Story

  • Mad Men--Why Gen Y Women Need To Tune In

    Forbes.com - 8/14/09 - View Story

  • White House invited med industry execs in early

    Washington Post - 7/23/09 - View Story

  • Merck Issues Statement on WHO Study Showing First Evidence That Elimination of River Blindness is Feasible in Africa

    Pharma Live - 7/22/09 - View Story

  • Obama was meeting with health execs in February

    Washington Post - 7/22/09 - View Story

  • Drugmaker Merck posts 12 percent drop in 2Q profit

    Raleigh News & Observer - 7/21/09 - View Story

  • Drugmakers Merck, Schering - Plough beat luke...

    Canadian Business Magazine - 7/21/09 - View Story

  • Drugmakers Merck, Schering-Plough beat lukewarm second-quarter forecasts

    News 1130 - 7/21/09 - View Story

  • Merck Announces Second-Quarter 2009 Financial Results

    Pharma Live - 7/21/09 - View Story

  • Health Firms Gave Big to Baucus

    Washington Post - 7/21/09 - View Story

  • Industry Cash Flowed To Drafters of Reform: Key Senator Baucus Is a Leading Recipient

    Washington Post - 7/20/09 - View Story

  • Merck Issues Statement on WHO Study Showing First Evidence That Elimination of River Blindness...

    Forbes.com - 7/20/09 - View Story

  • Merck and Schering-Plough Resolve Previously Disclosed Investigation Under State Consumer Protection Statutes Related to VYTORIN(ezetimibe/simvastatin) and ZETIA (ezetimibe)

    Pharma Live - 7/17/09 - View Story

  • Sun Valley: The stars align

    Reuters - 7/07/09 - View Story

  • White House Assures Drug Makers on Reimportation

    The Wall Street Journal Interactive Edition - 7/07/09 - View Story

  • Netezza appoints new board member

    TradingMarkets - 6/26/09 - View Story

  • 2009 Medical Innovation Summit at Cleveland Clinic to Highlight the Latest Developments...

    Reuters - 6/24/09 - View Story

  • 2009 Medical Innovation Summit at Cleveland Clinic to Highlight the Latest Developments in Cancer Care

    PR Newswire - 6/24/09 - View Story

  • Thomson Reuters Delisting a Sell Opportunity - UBS

    Seeking Alpha - 6/23/09 - View Story

  • Thomson Reuters UK delisting to force stake sales

    Forbes.com - 6/23/09 - View Story

advertisement
Click Here
     MRK $37.07 -0.47 (-1.25% )
Average Volume 19,947,100
Shares Outstanding 2.11B
Market Cap 78.2B
Year High 37.92
Year Low 20.05
Earnings Per Share 3.80
P/E Ratio 9.76
Dividend N/A
Yield N/A
advertisement